{"name": "Syndax Pharmaceuticals",
 "permalink": "sndax-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/sndax-pharmaceuticals",
 "homepage_url": "http://www.syndax.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@syndax.com",
 "phone_number": "781.419.1400",
 "description": "Cancer Therapeutics Developer",
 "created_at": "Tue Mar 16 07:10:48 UTC 2010",
 "updated_at": "Thu Apr 19 03:57:02 UTC 2012",
 "overview": "\u003Cp\u003ESyndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       60],
      "assets/images/resized/0008/0485/80485v1-max-150x150.png"],
     [[206,
       83],
      "assets/images/resized/0008/0485/80485v1-max-250x250.png"],
     [[206,
       83],
      "assets/images/resized/0008/0485/80485v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board Chairman",
    "person":
     {"first_name": "Dennis",
      "last_name": "Podlesak",
      "permalink": "dennis-podlesak",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5334/265334v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5334/265334v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5334/265334v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Arlene",
      "last_name": "M. Morris",
      "permalink": "arlene-m-morris",
      "image": null}},
   {"is_past": false,
    "title": "President",
    "person":
     {"first_name": "Joanna",
      "last_name": "C. Horobin",
      "permalink": "joanna-c-horobin",
      "image": null}},
   {"is_past": false,
    "title": "Board Observer",
    "person":
     {"first_name": "Eckard",
      "last_name": "Weber",
      "permalink": "eckard-weber",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Member of Board",
    "person":
     {"first_name": "Artthur",
      "last_name": "M. Pappas",
      "permalink": "artthur-m-pappas",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0026/7047/267047v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/7047/267047v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/7047/267047v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Founding CEO",
    "person":
     {"first_name": "Eckard",
      "last_name": "Weber",
      "permalink": "eckard-weber",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$9M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/syndax-pharmaceuticals-inc-series-a-9m/",
    "source_description": "Syndax Pharmaceuticals, Inc.: Series A $9M",
    "raised_amount": 9000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Avalon Ventures",
         "permalink": "avalon-ventures",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0002/2500/22500v2-max-150x150.png"],
             [[250,
               30],
              "assets/images/resized/0002/2500/22500v2-max-250x250.png"],
             [[272,
               33],
              "assets/images/resized/0002/2500/22500v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Forward Ventures",
         "permalink": "forward-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9546/49546v1-max-150x150.png"],
             [[250,
               33],
              "assets/images/resized/0004/9546/49546v1-max-250x250.png"],
             [[384,
               52],
              "assets/images/resized/0004/9546/49546v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pappas Ventures",
         "permalink": "pappas-ventures",
         "image":
          {"available_sizes":
            [[[150,
               131],
              "assets/images/resized/0004/9245/49245v1-max-150x150.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-250x250.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "460 Totten Pond Road",
    "address2": "Suite 650",
    "zip_code": "02451",
    "city": "Waltham",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        93],
       "assets/images/resized/0008/0823/80823v1-max-150x150.jpg"],
      [[250,
        156],
       "assets/images/resized/0008/0823/80823v1-max-250x250.jpg"],
      [[450,
        281],
       "assets/images/resized/0008/0823/80823v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}